ABERA BIOSCIENCE AB (8WK) — Financial Flexibility Index
Latest as of December 2025:
-0.08x
ABERA BIOSCIENCE AB (8WK) has a Financial Flexibility Index of -0.08x as of December 2025. Free cash flow of €-743.00K (operating CF €-815.00K minus capex €72.00K) represents 0% of total liabilities (€9.28 Million).
Financial Flexibility Index
-0.08x
Free Cash Flow / Total Liabilities
Free Cash Flow
€-743.00K
Operating CF − Capex
Total Liabilities
€9.28 Million
EUR
Capital Expenditures
€72.00K
EUR
ABERA BIOSCIENCE AB Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for ABERA BIOSCIENCE AB across 4 annual periods. See working capital position of ABERA BIOSCIENCE AB to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ABERA BIOSCIENCE AB (2022–2025)
Year-by-year free cash flow to debt coverage for ABERA BIOSCIENCE AB. For the full company profile including market capitalisation, see ABERA BIOSCIENCE AB market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.31x | €-2.83 Million | €-3.26 Million | €9.28 Million | ▼ -261.8% |
| 2024 | 0.19x | €933.00K | €-198.00K | €4.95 Million | ▲ +103.9% |
| 2023 | -4.80x | €-17.71 Million | €-17.71 Million | €3.69 Million | ▲ +31.9% |
| 2022 | -7.05x | €-19.69 Million | €-19.69 Million | €2.80 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities